Trial Profile
OTIS Autoimmune Diseases in Pregnancy Project
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2023
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Juvenile rheumatoid arthritis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Amgen
- 29 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Jan 2014 Status changed from recruiting to active, no longer recruiting, ClinicalTrials.gov (NCT00116272).